iRhythm Holdings, Inc.IRTC财报
Nasdaq · 医疗保健 · 外科及医疗仪器和设备
iRhythm Holdings是一家专注于心脏护理领域的数字医疗企业，开发可穿戴动态心脏监测设备及配套AI分析工具，主要服务美国市场的医疗机构与患者，帮助检测房颤等心律异常病症，为临床诊断提供可靠的数据支持。
IRTC Q4 2025 Key Financial Metrics
营收
$208.9M
毛利润
$148.1M
营业利润
$2.3M
净利润
$5.6M
毛利率
70.9%
营业利润率
1.1%
净利率
2.7%
同比增长
27.1%
EPS
$0.18
资金流向
iRhythm Holdings, Inc. Q4 2025 财务摘要
iRhythm Holdings, Inc. Q4 2025营收 $208.9M（同比增长 27.1%），净利润 $5.6M（同比增长 518.5%）（净利率 2.7%）。销售成本 $60.8M，运营费用 $145.8M。
核心财务指标
| 总营收 | $208.9M |
|---|---|
| 净利润 | $5.6M |
| 毛利率 | 70.9% |
| 营业利润率 | 1.1% |
| 报告期 | Q4 2025 |
营收拆解
iRhythm Holdings, Inc. Q4 2025营收 $208.9M 共来自 4 个业务板块，最大板块 Commercial Payors 贡献 $111.7M（占 53.5%）。
| 业务分部 | 营收 | 占比 |
|---|---|---|
| Commercial Payors | $111.7M | 53.5% |
| Centers For Medicare And Medicaid | $49.2M | 23.5% |
| Healthcare Institutions | $34.3M | 16.4% |
| Non Contracted Third Party Payors | $13.7M | 6.5% |
iRhythm Holdings, Inc. 分部营收 — 季度趋势
iRhythm Holdings, Inc. 过去 4 个季度各业务板块营收走势，展示 Commercial Payors and Centers For Medicare And Medicaid 等业务的变化。
| 业务分部 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Commercial Payors | $111.7M | $99.0M | $97.7M | $83.8M |
| Centers For Medicare And Medicaid | $49.2M | $47.6M | $44.5M | $38.1M |
| Healthcare Institutions | $34.3M | $32.8M | $31.8M | $26.7M |
| Non Contracted Third Party Payors | $13.7M | $13.5M | $12.7M | $10.1M |
iRhythm Holdings, Inc. 年度营收
iRhythm Holdings, Inc. 历年营收汇总，含各年度总量（例如 2025 年营收为 $747.1M）。点击带链接的年份，查看该年度相比前一年的财报变化。
iRhythm Holdings, Inc. 季度营收与净利润历史
iRhythm Holdings, Inc. 最近 8 个季度的营收、净利润及同比增速
| 季度 | 营收 | 营收同比 | 净利润 | 净利率 |
|---|---|---|---|---|
| Q4 2025 | $208.9M | +27.1% | $5.6M | 2.7% |
| Q3 2025 | $192.9M | +30.7% | $-5.2M | -2.7% |
| Q2 2025 | $186.7M | +26.1% | $-14.2M | -7.6% |
| Q1 2025 | $158.7M | +20.3% | $-30.7M | -19.3% |
| Q4 2024 | $164.3M | +24.0% | $-1.3M | -0.8% |
| Q3 2024 | $147.5M | +18.4% | $-46.2M | -31.3% |
| Q2 2024 | $148.0M | +19.3% | $-20.1M | -13.6% |
| Q1 2024 | $131.9M | +18.4% | $-45.7M | -34.6% |
利润表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 营收 | $131.9M | $148.0M | $147.5M | $164.3M | $158.7M | $186.7M | $192.9M | $208.9M |
| 同比增长 | 18.4% | 19.3% | 18.4% | 24.0% | 20.3% | 26.1% | 30.7% | 27.1% |
资产负债表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 总资产 | $909.8M | $919.2M | $909.7M | $931.4M | $926.1M | $964.0M | $995.2M | $1.02B |
| 总负债 | $819.5M | $820.0M | $837.9M | $840.5M | $839.4M | $860.4M | $873.3M | $867.3M |
| 股东权益 | $90.3M | $99.2M | $71.8M | $90.9M | $86.7M | $103.7M | $121.9M | $152.7M |
现金流量表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 经营性现金流 | $-52.0M | $11.8M | $24.3M | $19.2M | $-7.9M | $27.7M | $34.9M | $26.2M |